190 related articles for article (PubMed ID: 32060362)
1. Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials.
Sahebkar A; Simental-Mendía LE; Pirro M; Banach M; Watts GF; Sirtori C; Al-Rasadi K; Atkin SL
Sci Rep; 2020 Feb; 10(1):2999. PubMed ID: 32060362
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J
Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Awad K; Mikhailidis DP; Katsiki N; Muntner P; Banach M;
Drugs; 2018 Mar; 78(4):453-462. PubMed ID: 29396832
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials.
Sahebkar A; Simental-Mendía LE; Watts GF; Serban MC; Banach M;
BMC Med; 2017 Feb; 15(1):22. PubMed ID: 28153024
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials.
Pandor A; Ara RM; Tumur I; Wilkinson AJ; Paisley S; Duenas A; Durrington PN; Chilcott J
J Intern Med; 2009 May; 265(5):568-80. PubMed ID: 19141093
[TBL] [Abstract][Full Text] [Related]
6. Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Tani H; Takasu S; Uchida H; Suzuki T; Mimura M; Takeuchi H
Neuropsychopharmacology; 2020 Apr; 45(5):902. PubMed ID: 31974442
[TBL] [Abstract][Full Text] [Related]
7. Author Correction: The prevalence of microsporidia in China: A systematic review and meta-analysis.
Qiu L; Xia W; Li W; Ping J; Ding S; Liu H
Sci Rep; 2019 Dec; 9(1):18482. PubMed ID: 31811164
[TBL] [Abstract][Full Text] [Related]
8. Correction: The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials.
Akbari M; Ostadmohammadi V; Mirhosseini N; Lankarani KB; Tabrizi R; Keshtkaran Z; Reiter RJ; Asemi Z
J Hum Hypertens; 2020 May; 34(5):413. PubMed ID: 31645639
[TBL] [Abstract][Full Text] [Related]
9. Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes.
Fei Y; Guyatt GH; Alexander PE; El Dib R; Siemieniuk RAC; Vandvik PO; Nunnally ME; Gomaa H; Morgan RL; Agarwal A; Zhang Y; Bhatnagar N; Spencer FA
J Eval Clin Pract; 2018 Feb; 24(1):222-231. PubMed ID: 28090731
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis.
Kemi N; Eskuri M; Kauppila JH
Sci Rep; 2020 Mar; 10(1):5183. PubMed ID: 32179847
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: The association between physical activity and low back pain: a systematic review and meta-analysis of observational studies.
Alzahrani H; Mackey M; Stamatakis E; Zadro JR; Shirley D
Sci Rep; 2020 Apr; 10(1):5987. PubMed ID: 32238867
[TBL] [Abstract][Full Text] [Related]
12. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
[TBL] [Abstract][Full Text] [Related]
14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
15. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
Assmann G; Kannenberg F; Ramey DR; Musliner TA; Gutkin SW; Veltri EP
Curr Med Res Opin; 2008 Jan; 24(1):249-59. PubMed ID: 18053317
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial.
Morimoto T; Sakuma I; Sakuma M; Tokushige A; Natsuaki M; Asahi T; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
Sci Rep; 2020 Feb; 10(1):3548. PubMed ID: 32080316
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.
Gudzune KA; Monroe AK; Sharma R; Ranasinghe PD; Chelladurai Y; Robinson KA
Ann Intern Med; 2014 Apr; 160(7):468-76. PubMed ID: 24514899
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.
Sharma M; Ansari MT; Abou-Setta AM; Soares-Weiser K; Ooi TC; Sears M; Yazdi F; Tsertsvadze A; Moher D
Ann Intern Med; 2009 Nov; 151(9):622-30. PubMed ID: 19884623
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF
Curr Pharm Des; 2016; 22(5):595-608. PubMed ID: 26601964
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
